Adachi Kai, Okuwaki Kosuke, Nishiyama Ryo, Kida Mitsuhiro, Imaizumi Hiroshi, Iwai Tomohisa, Yamauchi Hiroshi, Kaneko Toru, Hasegawa Rikiya, Miyata Eiji, Kumamoto Yusuke, Koizumi Wasaburo
Department of Gastroenterology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami, Sagamihara, Kanagawa, 252-0375, Japan.
Department of Surgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami, Sagamihara, Kanagawa, 252-0375, Japan.
Clin J Gastroenterol. 2019 Oct;12(5):466-472. doi: 10.1007/s12328-019-00972-0. Epub 2019 Apr 2.
The patient was a 69-year-old female with a chief complaint of yellow staining of her urine. A detailed physical examination and laboratory tests were carried out, and as a result, her condition was diagnosed as unresectable advanced extrahepatic cholangiocarcinoma with liver metastases. Chemotherapy using gemcitabine + cisplatin was initiated, and computed tomography after six cycles revealed that the liver metastases had disappeared, and that a partial response was achieved in the primary tumor. After tan cycles, a pylorus-preserving pancreaticoduodenectomy was performed as conversion surgery, and as a result, a pathological complete response was achieved in the primary tumor. After the primary lesion was resected, we were able to start an adjuvant chemotherapy immediately. Approximately 19 months have passed since the surgery, and the patient is currently alive and recurrence-free. If an improvement of the outcomes of chemotherapy in unresectable advanced biliary tract carcinomas is achieved in the future, there could be an increase in the number of treatment-responsive cases like the one reported in this study. Accumulating a large number of cases successfully treated by conversion surgery, and conducting a detailed analysis of the postoperative course, may help design adequate treatment strategies.
该患者为69岁女性,主诉尿液发黄。进行了详细的体格检查和实验室检查,结果诊断为无法切除的晚期肝外胆管癌伴肝转移。开始使用吉西他滨+顺铂进行化疗,六个周期后的计算机断层扫描显示肝转移消失,原发肿瘤部分缓解。十个周期后,进行了保留幽门的胰十二指肠切除术作为转化手术,结果原发肿瘤实现了病理完全缓解。切除原发病变后,我们能够立即开始辅助化疗。手术至今已过去约19个月,患者目前存活且无复发。如果未来不可切除的晚期胆管癌化疗效果得到改善,像本研究报道的这种治疗反应良好的病例数量可能会增加。积累大量通过转化手术成功治疗的病例,并对术后病程进行详细分析,可能有助于设计合适的治疗策略。